193 related articles for article (PubMed ID: 21981664)
21. Comparative study of the diagnostic and prognostic value of antibodies against chimeric citrullinated synthetic peptides and CCP3/CCP3.1 assays.
Gómara MJ; Rodríguez J; Bleda MJ; Salvador JP; Sanmartí R; Haro I
Clin Chem Lab Med; 2018 Jan; 56(2):285-293. PubMed ID: 28850543
[TBL] [Abstract][Full Text] [Related]
22. Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis.
Brink M; Hansson M; Mathsson L; Jakobsson PJ; Holmdahl R; Hallmans G; Stenlund H; Rönnelid J; Klareskog L; Rantapää-Dahlqvist S
Arthritis Rheum; 2013 Apr; 65(4):899-910. PubMed ID: 23310951
[TBL] [Abstract][Full Text] [Related]
23. Role of N- or C-terminal biotinylation in autoantibody recognition of citrullin containing filaggrin epitope peptides in rheumatoid arthritis.
Babos F; Szarka E; Nagy G; Majer Z; Sármay G; Magyar A; Hudecz F
Bioconjug Chem; 2013 May; 24(5):817-27. PubMed ID: 23617702
[TBL] [Abstract][Full Text] [Related]
24. A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis.
Svärd A; Kastbom A; Söderlin MK; Reckner-Olsson Å; Skogh T
J Rheumatol; 2011 Jul; 38(7):1265-72. PubMed ID: 21459947
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic and prognostic value of antibodies against chimeric fibrin/filaggrin citrullinated synthetic peptides in rheumatoid arthritis.
Sanmartí R; Graell E; Perez ML; Ercilla G; Viñas O; Gómez-Puerta JA; Gratacós J; Balsa A; Gómara MJ; Larrosa M; Cañete JD; Haro I
Arthritis Res Ther; 2009; 11(5):R135. PubMed ID: 19725967
[TBL] [Abstract][Full Text] [Related]
26. Anti-citrullinated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients.
Barra L; Scinocca M; Saunders S; Bhayana R; Rohekar S; Racapé M; Coles R; Cairns E; Bell DA
Arthritis Rheum; 2013 Jun; 65(6):1439-47. PubMed ID: 23450693
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic value of anti-cyclic citrullinated Peptide antibody in patients with rheumatoid arthritis.
Zeng X; Ai M; Tian X; Gan X; Shi Y; Song Q; Tang F
J Rheumatol; 2003 Jul; 30(7):1451-5. PubMed ID: 12858440
[TBL] [Abstract][Full Text] [Related]
28. The antigen specificity of the rheumatoid arthritis-associated ACPA directed to citrullinated fibrin is very closely restricted.
Iobagiu C; Magyar A; Nogueira L; Cornillet M; Sebbag M; Arnaud J; Hudecz F; Serre G
J Autoimmun; 2011 Dec; 37(4):263-72. PubMed ID: 21872430
[TBL] [Abstract][Full Text] [Related]
29. Technical and diagnostic performance of 6 assays for the measurement of citrullinated protein/peptide antibodies in the diagnosis of rheumatoid arthritis.
Coenen D; Verschueren P; Westhovens R; Bossuyt X
Clin Chem; 2007 Mar; 53(3):498-504. PubMed ID: 17259232
[TBL] [Abstract][Full Text] [Related]
30. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies.
Schellekens GA; de Jong BA; van den Hoogen FH; van de Putte LB; van Venrooij WJ
J Clin Invest; 1998 Jan; 101(1):273-81. PubMed ID: 9421490
[TBL] [Abstract][Full Text] [Related]
31. Humoral immune response to citrullinated collagen type II determinants in early rheumatoid arthritis.
Burkhardt H; Sehnert B; Bockermann R; Engström A; Kalden JR; Holmdahl R
Eur J Immunol; 2005 May; 35(5):1643-52. PubMed ID: 15832289
[TBL] [Abstract][Full Text] [Related]
32. Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis.
van Venrooij WJ; Zendman AJ; Pruijn GJ
Autoimmun Rev; 2006 Nov; 6(1):37-41. PubMed ID: 17110315
[TBL] [Abstract][Full Text] [Related]
33. Citrullinated peptide and its relevance to rheumatoid arthritis: an update.
Luban S; Li ZG
Int J Rheum Dis; 2010 Oct; 13(4):284-7. PubMed ID: 21199462
[TBL] [Abstract][Full Text] [Related]
34. [Anticitrullin antibodies--modern markers of rheumatoid arthritis].
Shilkina NP; Luzinova MS; Vinogradov AA
Ter Arkh; 2011; 83(1):70-5. PubMed ID: 21446207
[TBL] [Abstract][Full Text] [Related]
35. Mutated citrullinated vimentin antibodies in rheumatoid arthritis.
Kuna AT
Clin Chim Acta; 2012 Jan; 413(1-2):66-73. PubMed ID: 22037509
[TBL] [Abstract][Full Text] [Related]
36. Carbon nanotube composite peptide-based biosensors as putative diagnostic tools for rheumatoid arthritis.
Villa Mde G; Jiménez-Jorquera C; Haro I; Gomara MJ; Sanmartí R; Fernández-Sánchez C; Mendoza E
Biosens Bioelectron; 2011 Sep; 27(1):113-8. PubMed ID: 21764288
[TBL] [Abstract][Full Text] [Related]
37. The role of anti-mutated citrullinated vimentin antibodies in the diagnosis of early rheumatoid arthritis.
Liu X; Jia R; Zhao J; Li Z
J Rheumatol; 2009 Jun; 36(6):1136-42. PubMed ID: 19447936
[TBL] [Abstract][Full Text] [Related]
38. The epitopes targeted by the rheumatoid arthritis-associated antifilaggrin autoantibodies are posttranslationally generated on various sites of (pro)filaggrin by deimination of arginine residues.
Girbal-Neuhauser E; Durieux JJ; Arnaud M; Dalbon P; Sebbag M; Vincent C; Simon M; Senshu T; Masson-Bessière C; Jolivet-Reynaud C; Jolivet M; Serre G
J Immunol; 1999 Jan; 162(1):585-94. PubMed ID: 9886436
[TBL] [Abstract][Full Text] [Related]
39. Rheumatoid arthritis specific anti-Sa antibodies target citrullinated vimentin.
Vossenaar ER; Després N; Lapointe E; van der Heijden A; Lora M; Senshu T; van Venrooij WJ; Ménard HA
Arthritis Res Ther; 2004; 6(2):R142-50. PubMed ID: 15059278
[TBL] [Abstract][Full Text] [Related]
40. [Anti-cyclic citrullinated peptide antibodies as a diagnostic test for rheumatoid arthritis].
Orbach H; Shoenfeld Y
Harefuah; 2003 Mar; 142(3):182-5, 239. PubMed ID: 12696470
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
